FI854330A0 - Torrsubstanser och stabila suspensioner. - Google Patents

Torrsubstanser och stabila suspensioner.

Info

Publication number
FI854330A0
FI854330A0 FI854330A FI854330A FI854330A0 FI 854330 A0 FI854330 A0 FI 854330A0 FI 854330 A FI854330 A FI 854330A FI 854330 A FI854330 A FI 854330A FI 854330 A0 FI854330 A0 FI 854330A0
Authority
FI
Finland
Prior art keywords
torrsubstanser
suspensioner
stabila
och
substances
Prior art date
Application number
FI854330A
Other languages
English (en)
Other versions
FI854330A (fi
FI85809B (fi
FI85809C (fi
Inventor
Leo Geller
Peter Glanzmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI854330A0 publication Critical patent/FI854330A0/fi
Publication of FI854330A publication Critical patent/FI854330A/fi
Publication of FI85809B publication Critical patent/FI85809B/fi
Application granted granted Critical
Publication of FI85809C publication Critical patent/FI85809C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
FI854330A 1984-11-06 1985-11-04 Foerfarande foer framstaellning av genom lyofilisering erhaollbara torrsubstanser. FI85809C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH530584 1984-11-06
CH530584 1984-11-06

Publications (4)

Publication Number Publication Date
FI854330A0 true FI854330A0 (fi) 1985-11-04
FI854330A FI854330A (fi) 1986-05-07
FI85809B FI85809B (fi) 1992-02-28
FI85809C FI85809C (fi) 1992-06-10

Family

ID=4291364

Family Applications (1)

Application Number Title Priority Date Filing Date
FI854330A FI85809C (fi) 1984-11-06 1985-11-04 Foerfarande foer framstaellning av genom lyofilisering erhaollbara torrsubstanser.

Country Status (26)

Country Link
US (1) US5002940A (fi)
EP (2) EP0346953B1 (fi)
JP (2) JPS61204118A (fi)
KR (1) KR890000907B1 (fi)
AT (2) ATE84718T1 (fi)
AU (2) AU586988B2 (fi)
CA (1) CA1249223A (fi)
CY (2) CY1898A (fi)
DD (1) DD244292A5 (fi)
DE (2) DE3587020D1 (fi)
DK (1) DK162510C (fi)
ES (1) ES8701491A1 (fi)
FI (1) FI85809C (fi)
GR (1) GR852637B (fi)
HK (2) HK101192A (fi)
HU (1) HU195728B (fi)
IE (2) IE63156B1 (fi)
IL (1) IL76943A (fi)
MX (1) MX9203371A (fi)
NL (1) NL940015I2 (fi)
NO (1) NO169324C (fi)
NZ (2) NZ229276A (fi)
PH (1) PH21673A (fi)
PT (1) PT81429B (fi)
SG (1) SG107192G (fi)
ZA (1) ZA858481B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH673395A5 (fi) * 1987-01-30 1990-03-15 Ciba Geigy Ag
MX9201782A (es) * 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
JP2002532389A (ja) * 1998-12-08 2002-10-02 ファレス ファーマシューティカル リサーチ エヌブイ リン脂質組成物
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
US6487907B1 (en) * 1999-07-08 2002-12-03 California Institute Of Technology Microgyroscope with integrated vibratory element
US20050100608A1 (en) * 2003-02-21 2005-05-12 Watson Pharmaceuticals, Inc. Testosterone oral dosage formulations and associated methods
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
WO2009026473A2 (en) * 2007-08-21 2009-02-26 Hollis-Eden Pharmaceuticals, Inc. Stabilized therapeutic compositions and formulations
WO2019213286A1 (en) * 2018-05-02 2019-11-07 LifeMax Laboratories, Inc. Extended release suspension formulation of lurasidone

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068447A1 (en) * 1969-11-26 1971-08-27 Orsymonde Dehydrated pharmaceutical comps by - lyophilisation
LU77457A1 (fi) * 1977-05-31 1979-01-19
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
JPS58206513A (ja) * 1982-05-28 1983-12-01 Eisai Co Ltd セクレチン吸着防止組成物および方法
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
DE3339295A1 (de) * 1982-11-15 1984-05-17 Schering AG, 1000 Berlin und 4709 Bergkamen 4-hydroxy- und 4-acyloxy-4-androsten-3,17-dione zur verwendung bei der prophylaxe und therapie der prostatahyperplasie und diese enthaltende mittel fuer derartige verwendung
EP0117811A3 (fr) * 1983-02-23 1987-06-03 Sanofi S.A. Compositions pharmaceutiques antifongiques utilisables par voie orale
EP0226021A1 (de) * 1985-12-12 1987-06-24 BBC Brown Boveri AG Thyristor mit schaltbarem Emitter-Kurzschluss

Also Published As

Publication number Publication date
PH21673A (en) 1988-01-13
ES548492A0 (es) 1986-12-01
NZ229276A (en) 1989-08-29
IE852755L (en) 1986-05-06
PT81429A (en) 1985-12-01
CY1677A (en) 1993-10-10
AU633844B2 (en) 1993-02-11
IE902490L (en) 1986-05-06
NO854403L (no) 1986-05-07
MX9203371A (es) 1992-09-01
IL76943A (en) 1990-02-09
CY1898A (en) 1985-10-31
ZA858481B (en) 1986-06-25
NL940015I2 (nl) 1997-01-06
EP0181287A3 (en) 1987-09-23
FI854330A (fi) 1986-05-07
EP0346953A3 (en) 1990-11-22
EP0181287A2 (de) 1986-05-14
DD244292A5 (de) 1987-04-01
CA1249223A (en) 1989-01-24
DK162510C (da) 1992-03-30
FI85809B (fi) 1992-02-28
IE63166B1 (en) 1995-03-22
NZ214069A (en) 1989-08-29
JPS61204118A (ja) 1986-09-10
SG107192G (en) 1992-12-24
NL940015I1 (nl) 1994-10-17
NO169324C (no) 1992-06-10
KR890000907B1 (ko) 1989-04-13
AU4934485A (en) 1986-05-15
HUT42936A (en) 1987-09-28
KR860003825A (ko) 1986-06-13
DE3587020D1 (de) 1993-03-04
EP0346953B1 (de) 1993-01-20
HK192095A (en) 1995-12-29
AU586988B2 (en) 1989-08-03
GR852637B (fi) 1986-03-04
ES8701491A1 (es) 1986-12-01
DK162510B (da) 1991-11-11
AU4150489A (en) 1990-01-04
JPH0558410B2 (fi) 1993-08-26
IE63156B1 (en) 1995-03-22
HU195728B (en) 1988-07-28
DE3576650D1 (de) 1990-04-26
HK101192A (en) 1992-12-24
ATE51152T1 (de) 1990-04-15
DK509485D0 (da) 1985-11-05
ATE84718T1 (de) 1993-02-15
PT81429B (pt) 1988-03-03
US5002940A (en) 1991-03-26
NO169324B (no) 1992-03-02
EP0181287B1 (de) 1990-03-21
JPH0648945A (ja) 1994-02-22
DK509485A (da) 1986-05-07
FI85809C (fi) 1992-06-10
EP0346953A2 (de) 1989-12-20
JPH0768130B2 (ja) 1995-07-26

Similar Documents

Publication Publication Date Title
IL77133A (en) Antineoplastic pharmaceutical compositions containing pentofuranoside derivatives,some new such compounds and their preparation
ES537578A0 (es) Procedimiento para la estabilizacion de preparados farmaceuticos en forma de suspensiones conteniendo sucralfato
FI860483A (fi) Komposition och foerfarande foer flotation av stenkol ur raostenkol.
FI854330A0 (fi) Torrsubstanser och stabila suspensioner.
FI832072A0 (fi) 1,4-dihydropyridiner i optiskt aktiv eller racematform, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
DE3583015D1 (de) Phospholipidkonjugate und deren herstellung.
SE8503513D0 (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
FR2432505B1 (fr) Nouveaux sels de 5-iodo-3-nitro-4-hydroxybenzonitrile, leur preparation et compositions qui les contiennent
RO95350A2 (ro) Procedeu de obtinere a unei compozitii medicamentoase solide
ES509390A0 (es) "perfeccionamientos introducidos en la estructura de los quemadores de combustibles solidos".
ES510600A0 (es) "procedimiento para la obtencion de levadura en polvo de estabilidad mejorada".

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG

MA Patent expired